Abstract
Little is known about the relation of multivitamin use to breast cancer outcomes. 2,236 women diagnosed from 1997 to 2000 with early-stage breast cancer (Stage I ≥ 1 cm, II, or IIIA) were enrolled about 2 years post-diagnosis, primarily from the Kaiser Permanente Northern California Cancer Registry (83%). Multivitamin use pre-diagnosis and post-diagnosis was assessed via mailed questionnaire. Outcomes were ascertained yearly by self-report and verified by medical record review. Delayed-entry Cox proportional hazards models were used to estimate hazard ratios (HR) and 95% confidence intervals (CI), adjusting for sociodemographic, tumor, and lifestyle factors. Overall, 54 and 72% of the cohort reported using multivitamins pre- and post-diagnosis, respectively. A total of 380 recurrences, 212 breast cancer deaths, and 396 total deaths were confirmed. Compared to never use, multivitamin use after diagnosis was not associated with any outcome (recurrence HR = 0.92; 95% CI: 0.71, 1.20; total mortality HR = 0.92; 95% CI: 0.71, 1.19). Compared to never use, persistent use of multivitamins from pre- to post-diagnosis was associated with a non-significant decreased risk of recurrence (HR = 0.76; 95% CI: 0.54, 1.06) and total mortality (HR = 0.79; 95% CI: 0.56, 1.12). The protective associations were limited to women who had been treated by radiation only (P for trend = 0.048 and 0.083 for recurrence and total mortality, respectively) and both radiation and chemotherapy (P for trend = 0.015 and 0.095 for recurrence and total mortality, respectively). In stratified analyses, women who consistently used multivitamins before and after diagnosis and ate more fruits/vegetables (P for trend = 0.008) and were more physically active (P for trend = 0.034) had better overall survival. Multivitamin use along with practice of other health-promoting behaviors may be beneficial in improving breast cancer outcomes in select groups of survivors.
Similar content being viewed by others
References
American Cancer Society Breast Cancer Facts & Figures 2009–2010. American Cancer Society, Inc., Atlanta
Velicer CM, Ulrich CM (2008) Vitamin and mineral supplement use among US adults after cancer diagnosis: a systematic review. J Clin Oncol 26(4):665–673
Radimer K et al (2004) Dietary supplement use by US adults: data from the National Health and Nutrition Examination Survey, 1999–2000. Am J Epidemiol 160(4):339–349
Giovannucci E, Chan AT (2010) Role of vitamin and mineral supplementation and aspirin use in cancer survivors. J Clin Oncol 28(26):4081–4085
Nechuta S et al (2011) Vitamin supplement use during breast cancer treatment and survival: a prospective cohort study. Cancer Epidemiol Biomarkers Prev 20(2):262–271
Caan B et al (2005) Life After Cancer Epidemiology (LACE) Study: a cohort of early stage breast cancer survivors (United States). Cancer Causes Control 16(5):545–556
Block G et al (1986) A data-based approach to diet questionnaire design and testing. Am J Epidemiol 124(3):453–469
Staten LK et al (2001) Validation of the Arizona Activity Frequency Questionnaire using doubly labeled water. Med Sci Sports Exerc 33(11):1959–1967
Cox DR, Oakes D (1994) Analysis of survival data. Monographs in statistics and applied probability 21. Chapman & Hall, New York
Therneau TM, Grambsch PM (2000) Modeling survival data: Extending the Cox Model. Statistics for biology and health. Springer-Verlag, New York
Mickey RM, Greenland S (1989) The impact of confounder selection criteria on effect estimation. Am J Epidemiol 129(1):125–137
Reddy BS (1996) Micronutrients as chemopreventive agents. IARC Sci Publ 139:221–235
Kelloff GJ et al (1996) Mechanistic considerations in the evaluation of chemopreventive data. IARC Sci Publ 139:203–219
Asgari MM et al (2009) Antioxidant supplementation and risk of incident melanomas: results of a large prospective cohort study. Arch Dermatol 145(8):879–882
Cho E et al (2006) Intakes of vitamins A, C and E and folate and multivitamins and lung cancer: a pooled analysis of 8 prospective studies. Int J Cancer 118(4):970–978
Giovannucci E et al (1998) Multivitamin use, folate, and colon cancer in women in the Nurses’ Health Study. Ann Intern Med 129(7):517–524
Ishitani K et al (2008) A prospective study of multivitamin supplement use and risk of breast cancer. Am J Epidemiol 167(10):1197–1206
Jacobs EJ et al (2003) Multivitamin use and colorectal cancer incidence in a US cohort: does timing matter? Am J Epidemiol 158(7):621–628
Larsson SC et al (2010) Multivitamin use and breast cancer incidence in a prospective cohort of Swedish women. Am J Clin Nutr 91(5):1268–1272
Meulepas JM et al (2010) Multivitamin supplement use and risk of invasive breast cancer. Public Health Nutr 13(10):1540–1545
Neuhouser ML et al (2009) Multivitamin use and risk of cancer and cardiovascular disease in the Women’s Health Initiative cohorts. Arch Intern Med 169(3):294–304
Thompson CA et al (2010) Antioxidant intake from fruits, vegetables and other sources and risk of non-Hodgkin’s lymphoma: the Iowa Women’s Health Study. Int J Cancer 126(4):992–1003
Zhang S et al (1999) Dietary carotenoids and vitamins A, C, and E and risk of breast cancer. J Natl Cancer Inst 91(6):547–556
Zhang SM et al (2001) Vitamin supplement use and the risk of non-Hodgkin’s lymphoma among women and men. Am J Epidemiol 153(11):1056–1063
Zhang Y et al (2009) Vitamin and mineral use and risk of prostate cancer: the case-control surveillance study. Cancer Causes Control 20(5):691–698
Jacobs EJ et al (2002) Vitamin C, vitamin E, and multivitamin supplement use and stomach cancer mortality in the Cancer Prevention Study II cohort. Cancer Epidemiol Biomarkers Prev 11(1):35–41
Jacobs EJ et al (2001) Multivitamin use and colon cancer mortality in the Cancer Prevention Study II cohort (United States). Cancer Causes Control 12(10):927–934
Pocobelli G et al (2009) Use of supplements of multivitamins, vitamin C, and vitamin E in relation to mortality. Am J Epidemiol 170(4):472–483
Watkins ML et al (2000) Multivitamin use and mortality in a large prospective study. Am J Epidemiol 152(2):149–162
Greenlee H, Hershman DL, Jacobson JS (2009) Use of antioxidant supplements during breast cancer treatment: a comprehensive review. Breast Cancer Res Treat 115(3):437–452
Fleischauer AT, Simonsen N, Arab L (2003) Antioxidant supplements and risk of breast cancer recurrence and breast cancer-related mortality among postmenopausal women. Nutr Cancer 46(1):15–22
Lesperance ML et al (2002) Mega-dose vitamins and minerals in the treatment of non-metastatic breast cancer: an historical cohort study. Breast Cancer Res Treat 76(2):137–143
Lawenda BD et al (2008) Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy? J Natl Cancer Inst 100(11):773–783
Meyer F et al (2008) Interaction between antioxidant vitamin supplementation and cigarette smoking during radiation therapy in relation to long-term effects on recurrence and mortality: a randomized trial among head and neck cancer patients. Int J Cancer 122(7):1679–1683
Bairati I et al (2005) Randomized trial of antioxidant vitamins to prevent acute adverse effects of radiation therapy in head and neck cancer patients. J Clin Oncol 23(24):5805–5813
Simone CB 2nd et al (2007) Antioxidants and other nutrients do not interfere with chemotherapy or radiation therapy and can increase kill and increase survival, Part 2. Altern Ther Health Med 13(2):40–47
Simone CB 2nd et al (2007) Antioxidants and other nutrients do not interfere with chemotherapy or radiation therapy and can increase kill and increase survival, part 1. Altern Ther Health Med 13(1):22–28
Conklin KA (2000) Dietary antioxidants during cancer chemotherapy: impact on chemotherapeutic effectiveness and development of side effects. Nutr Cancer 37(1):1–18
Ratnam DV et al (2006) Role of antioxidants in prophylaxis and therapy: a pharmaceutical perspective. J Control Release 113(3):189–207
D’Andrea GM (2005) Use of antioxidants during chemotherapy and radiotherapy should be avoided. CA Cancer J Clin 55(5):319–321
Kwan ML et al (2009) Dietary patterns and breast cancer recurrence and survival among women with early-stage breast cancer. J Clin Oncol 27(6):919–926
Sternfeld B et al (2009) Physical activity and risk of recurrence and mortality in breast cancer survivors: findings from the LACE study. Cancer Epidemiol Biomarkers Prev 18(1):87–95
Millen AE, Dodd KW, Subar AF (2004) Use of vitamin, mineral, nonvitamin, and nonmineral supplements in the United States: The 1987, 1992, and 2000 National Health Interview Survey results. J Am Diet Assoc 104(6):942–950
Greenlee H et al (2009) Prevalence and predictors of antioxidant supplement use during breast cancer treatment: the Long Island Breast Cancer Study Project. Cancer 115(14):3271–3282
Newman V et al (1998) Dietary supplement use by women at risk for breast cancer recurrence. The Women’s Healthy Eating and Living Study Group. J Am Diet Assoc 98(3):285–292
Doyle C et al (2006) Nutrition and physical activity during and after cancer treatment: an American Cancer Society guide for informed choices. CA Cancer J Clin 56(6):323–353
Kushi LH et al (2006) American Cancer Society Guidelines on Nutrition and Physical Activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin 56(5):254–281 quiz 313-4
Acknowledgments
We thank Erin Weltzien for programming support, and all LACE study staff and participants. This study was funded by the National Cancer Institute (R01 CA129059). The contents of this article are solely the responsibility of the authors and do not necessarily represent the official views of the National Cancer Institute.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kwan, M.L., Greenlee, H., Lee, V.S. et al. Multivitamin use and breast cancer outcomes in women with early-stage breast cancer: the Life After Cancer Epidemiology study. Breast Cancer Res Treat 130, 195–205 (2011). https://doi.org/10.1007/s10549-011-1557-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-011-1557-4